{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:51:50Z","timestamp":1790074310689,"version":"4.0.1"},"reference-count":149,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T00:00:00Z","timestamp":1546819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"DOI":"10.3389\/fphys.2018.01853","type":"journal-article","created":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T04:26:09Z","timestamp":1546835169000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":46,"title":["Biocompatible Peritoneal Dialysis: The Target Is Still Way Off"],"prefix":"10.3389","volume":"9","author":[{"given":"Maria","family":"Bartosova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus Peter","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,1,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1007\/s11255-015-1116-8","article-title":"Effect of bevacizumab, a vascular endothelial growth factor inhibitor, on a rat model of peritoneal sclerosis","volume":"47","author":"Ada","year":"2015","journal-title":"Int. Urol. Nephrol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1681\/ASN.2006111292","article-title":"Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions","volume":"18","author":"Aroeira","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"4545","DOI":"10.3748\/wjg.v17.i41.4545","article-title":"Pathophysiology and prevention of postoperative peritoneal adhesions","volume":"17","author":"Arung","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.kint.2017.02.037","article-title":"Biomarker research to improve clinical outcomes of peritoneal dialysis: consensus of the European Training and Research in Peritoneal Dialysis (EuTRiPD) network","volume":"92","author":"Aufricht","year":"2017","journal-title":"Kidney Int."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/ndt\/gfq357","article-title":"Low-GDP peritoneal dialysis fluid (\u2018balance\u2019) has less impact in\u00a0vitro and ex\u00a0vivo on epithelial-to-mesenchymal transition (EMT) of mesothelial cells than a standard fluid","volume":"26","author":"Bajo","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1681\/asn.2017040436","article-title":"Complement activation in peritoneal dialysis-induced arteriolopathy","volume":"29","author":"Bartosova","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1007\/s00467-008-0834-x","article-title":"Biocompatibility of a bicarbonate-buffered amino-acid-based solution for peritoneal dialysis","volume":"23","author":"Bender","year":"2008","journal-title":"Pediatr. Nephrol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1146\/annurev-physiol-030212-183748","article-title":"Phosphate transporters and their function","volume":"75","author":"Biber","year":"2013","journal-title":"Annu. Rev. Physiol."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1053\/j.sempedsurg.2014.06.002","article-title":"Anatomy and physiology of the peritoneum","volume":"23","author":"Blackburn","year":"2014","journal-title":"Semin. Pediatr. Surg."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1053\/j.ajkd.2016.02.029","article-title":"Sodium levels in peritoneal dialysis solution: how low should we\u00a0go?","volume":"67","author":"Blake","year":"2016","journal-title":"Am. J. Kidney Dis."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.kint.2018.04.014","article-title":"Is the peritoneal dialysis biocompatibility hypothesis dead?","volume":"94","author":"Blake","year":"2018","journal-title":"Kidney Int."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1053\/j.ajkd.2013.04.007","article-title":"Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial","volume":"62","author":"Bonomini","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/ki.2011.117","article-title":"L-carnitine is an osmotic agent suitable for peritoneal dialysis","volume":"80","author":"Bonomini","year":"2011","journal-title":"Kidney Int."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/path.4119","article-title":"MicroRNAs, transforming growth factor beta-1, and tissue fibrosis","volume":"229","author":"Bowen","year":"2013","journal-title":"J. Pathol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e0166050","DOI":"10.1371\/journal.pone.0166050","article-title":"Reduced microvascular density in omental biopsies of children with chronic kidney disease","volume":"11","author":"Burkhardt","year":"2016","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1681\/asn.2013070799","article-title":"A pathogenetic role for endothelin-1\u00a0in peritoneal dialysis-associated fibrosis","volume":"26","author":"Busnadiego","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1681\/asn.2015101169","article-title":"IL-6 trans-signaling links inflammation with angiogenesis in the peritoneal membrane","volume":"28","author":"Catar","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/0007-1226(93)90050-L","article-title":"The effect of omental wrapping on nerve graft regeneration","volume":"46","author":"Chamorro","year":"1993","journal-title":"Br. J. Plast. Surg."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1681\/asn.2013101079","article-title":"Lineage tracing reveals distinctive fates for mesothelial cells and submesothelial fibroblasts during peritoneal injury","volume":"25","author":"Chen","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1093\/ndt\/gft050","article-title":"Impact of icodextrin on clinical outcomes in peritoneal dialysis: a systematic review of randomized controlled trials","volume":"28","author":"Cho","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"Cd007554","DOI":"10.1002\/14651858.CD007554.pub2","article-title":"Biocompatible dialysis fluids for peritoneal dialysis","volume":"3","author":"Cho","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref22","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1681\/ASN.V114717","article-title":"Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis","volume":"11","author":"Combet","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1038\/sj.ki.5002599","article-title":"Clinical outcomes and peritoneal histology in patients starting peritoneal dialysis are related to diabetic status and serum albumin levels","volume":"108","author":"Contreras-Velazquez","year":"2008","journal-title":"Kidney Int. Suppl."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1111\/j.1523-1755.2005.00243.x","article-title":"Longitudinal membrane function in functionally anuric patients treated with APD: data from EAPOS on the effects of glucose and icodextrin prescription","volume":"67","author":"Davies","year":"2005","journal-title":"Kidney Int."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1046\/j.1523-1755.1998.00180.x","article-title":"What really happens to people on long-term peritoneal dialysis?","volume":"54","author":"Davies","year":"1998","journal-title":"Kidney Int."},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1681\/ASN.V1251046","article-title":"Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis","volume":"12","author":"Davies","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/089686089001000203","article-title":"Peritoneal defence mechanisms and Staphylococcus aureus in patients treated with continuous ambulatory peritoneal dialysis (CAPD)","volume":"10","author":"Davies","year":"1990","journal-title":"Perit. Dial. Int."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.amjhyper.2007.03.016","article-title":"Structural alterations of subcutaneous small-resistance arteries may predict major cardiovascular events in patients with hypertension","volume":"20","author":"De Ciuceis","year":"2007","journal-title":"Am. J. Hypertens."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1001\/jama.2009.1488","article-title":"Cardiovascular and noncardiovascular mortality among patients starting dialysis","volume":"302","author":"de Jager","year":"2009","journal-title":"JAMA"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1681\/ASN.V1281734","article-title":"Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane","volume":"12","author":"De Vriese","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.lfs.2016.07.018","article-title":"Diabetes and exposure to peritoneal dialysis solutions alter tight junction proteins and glucose transporters of rat peritoneal mesothelial cells","volume":"161","author":"Debray-Garcia","year":"2016","journal-title":"Life Sci."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3747\/pdi.2014.00038","article-title":"Biocompatible dialysis solutions preserve peritoneal mesothelial cell and vessel wall integrity. A case-control study on human biopsies","volume":"36","author":"Del Peso","year":"2016","journal-title":"Perit. Dial. Int."},{"key":"ref33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1177\/089686089001000120","article-title":"Six-month overnight intraperitoneal amino-acid infusion in continuous ambulatory peritoneal dialysis (CAPD) patients\u2014no effect on nutritional status","volume":"10","author":"Dombros","year":"1990","journal-title":"Perit. Dial. Int."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s11255-017-1647-2","article-title":"Icodextrin and peritoneal dialysis: advantages and new applications","volume":"50","author":"Dousdampanis","year":"2018","journal-title":"Int. Urol. Nephrol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1186\/s12967-016-1098-z","article-title":"Hyperbranched polyglycerol is superior to glucose for long-term preservation of peritoneal membrane in a rat model of chronic peritoneal dialysis","volume":"14","author":"Du","year":"2016","journal-title":"J. Transl. Med."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e0189903","DOI":"10.1371\/journal.pone.0189903","article-title":"Bicarbonate buffered peritoneal dialysis fluid upregulates angiopoietin-1 and promotes vessel maturation","volume":"12","author":"Eich","year":"2017","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.yexcr.2013.03.011","article-title":"Angiopoietin signaling in the vasculature","volume":"319","author":"Eklund","year":"2013","journal-title":"Exp. Cell Res."},{"key":"ref38","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/089686080602600414","article-title":"How to avoid glucose degradation products in peritoneal dialysis fluids","volume":"26","author":"Erixon","year":"2006","journal-title":"Perit. Dial. Int."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1093\/ndt\/gfp384","article-title":"Celecoxib treatment reduces peritoneal fibrosis and angiogenesis and prevents ultrafiltration failure in experimental peritoneal dialysis","volume":"24","author":"Fabbrini","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.canlet.2012.08.018","article-title":"Angiopoietins in angiogenesis","volume":"328","author":"Fagiani","year":"2013","journal-title":"Cancer Lett."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3747\/pdi.2015.00031","article-title":"Effects of conversion to a bicarbonate\/lactate-buffered, neutral-pH, low-GDP PD regimen in prevalent PD: a 2-year randomized clinical trial","volume":"37","author":"Farhat","year":"2017","journal-title":"Perit. Dial. Int."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1159\/000045090","article-title":"Percutaneous renal biopsy in children: a 27-year experience","volume":"79","author":"Feneberg","year":"1998","journal-title":"Nephron"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.kint.2015.12.005","article-title":"The dipeptide alanyl-glutamine ameliorates peritoneal fibrosis and attenuates IL-17 dependent pathways during peritoneal dialysis","volume":"89","author":"Ferrantelli","year":"2016","journal-title":"Kidney Int."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.kint.2015.12.032","article-title":"Increasing sodium removal on peritoneal dialysis: applying dialysis mechanics to the peritoneal dialysis prescription","volume":"89","author":"Fischbach","year":"2016","journal-title":"Kidney Int."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1179\/016164101101198893","article-title":"Role of the omentum in the treatment of Alzheimer\u2019s disease","volume":"23","author":"Goldsmith","year":"2001","journal-title":"Neurol. Res."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"989560","DOI":"10.1155\/2015\/989560","article-title":"Rapamycin protects from type-I peritoneal membrane failure inhibiting the angiogenesis, lymphangiogenesis, and Endo-MT","volume":"2015","author":"Gonzalez-Mateo","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"ref47","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1177\/089686080602600610","article-title":"Improved in\u00a0vitro biocompatibility of bicarbonate-buffered peritoneal dialysis fluid","volume":"26","author":"Grossin","year":"2006","journal-title":"Perit. Dial. Int."},{"key":"ref48","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1177\/089686080702700611","article-title":"The expression patterns of peritoneal defensins","volume":"27","author":"Grupp","year":"2007","journal-title":"Perit. Dial. Int."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1093\/ndt\/gfq087","article-title":"Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: a prospective randomized study","volume":"25","author":"Haag-Weber","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1097\/01.asn.0000086475.83211.df","article-title":"Improved acidosis correction and recovery of mesothelial cell mass with neutral-pH bicarbonate dialysis solution among children undergoing automated peritoneal dialysis","volume":"14","author":"Haas","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0016-5085(98)70646-8","article-title":"The pathobiology of peritonitis","volume":"114","author":"Hall","year":"1998","journal-title":"Gastroenterology"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10047-015-0822-4","article-title":"Morphological characteristics in peritoneum in patients with neutral peritoneal dialysis solution","volume":"18","author":"Hamada","year":"2015","journal-title":"J. Artif. Organs"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00467-011-1939-1","article-title":"Epidemiology of chronic kidney disease in children","volume":"27","author":"Harambat","year":"2012","journal-title":"Pediatr. Nephrol."},{"key":"ref54","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/089686089801800203","article-title":"Surfactant barrier lining peritoneal mesothelium: lubricant and release agent","volume":"18","author":"Hills","year":"1998","journal-title":"Perit. Dial. Int."},{"key":"ref55","first-page":"72","article-title":"Restriction coefficients of low molecular weight solutes and macromolecules during peritoneal dialysis","volume":"13","author":"Ho-dac-Pannekeet","year":"1997","journal-title":"Adv. Perit. Dial."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S0039-6060(96)80196-6","article-title":"Fibrinolysis in human peritoneum during operation","volume":"119","author":"Holmdahl","year":"1996","journal-title":"Surgery"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/089686080902900217","article-title":"HPMCs induce greater intercellular delocalization of tight junction-associated proteins due to a higher susceptibility to H2O2 compared with HUVECs","volume":"29","author":"Horiuchi","year":"2009","journal-title":"Perit. Dial. Int."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3389\/fphys.2018.00738","article-title":"The peritoneum: beyond the tissue\u2014a review","volume":"9","author":"Isaza-Restrepo","year":"2018","journal-title":"Front. Physiol."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1159\/000069547","article-title":"Effect of glucose on intercellular junctions of cultured human peritoneal mesothelial cells","volume":"11","author":"Ito","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.atherosclerosis.2012.06.022","article-title":"Accumulation of tissue advanced glycation end products correlated with glucose exposure dose and associated with cardiovascular morbidity in patients on peritoneal dialysis","volume":"224","author":"Jiang","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1681\/asn.2011121201","article-title":"Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes","volume":"23","author":"Johnson","year":"","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1093\/ndt\/gfs314","article-title":"The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial","volume":"27","author":"Johnson","year":"","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3747\/pdi.2012.00052","article-title":"The effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: the balANZ trial","volume":"32","author":"Johnson","year":"","journal-title":"Perit. Dial. Int."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3747\/pdi.2011.00270","article-title":"Neutral solution\u00a0low in glucose degradation products is associated with less peritoneal fibrosis and vascular sclerosis in patients receiving peritoneal dialysis","volume":"33","author":"Kawanishi","year":"2013","journal-title":"Perit. Dial. Int."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"F1116","DOI":"10.1152\/ajprenal.00274.2017","article-title":"Thy-1(+\/\u2212) fibroblast subsets in the human peritoneum","volume":"313","author":"Kawka","year":"2017","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref66","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1177\/089686080802803s22","article-title":"Could solutions low in glucose degradation products preserve residual renal function in incident peritoneal dialysis patients? A 1-year multicenter prospective randomized controlled trial (Balnet Study)","volume":"28","author":"Kim","year":"2008","journal-title":"Perit. Dial. Int."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/ckj\/sfx149","article-title":"The European Renal Association\u00a0- European Dialysis and Transplant Association (ERA-EDTA) Registry Annual Report 2015: a summary","volume":"11","author":"Kramer","year":"2018","journal-title":"Clin. Kidney J."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"e0165045","DOI":"10.1371\/journal.pone.0165045","article-title":"Addition of alanyl-glutamine to dialysis fluid restores peritoneal cellular stress responses\u00a0- a first-in-man trial","volume":"11","author":"Kratochwill","year":"2016","journal-title":"PLoS One"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1093\/ndt\/gfr459","article-title":"Alanyl-glutamine dipeptide restores the cytoprotective stress proteome of mesothelial cells exposed to peritoneal dialysis fluids","volume":"27","author":"Kratochwill","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref70","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1177\/089686080002004S03","article-title":"Pathophysiology of peritoneal membrane failure","volume":"20","author":"Krediet","year":"2000","journal-title":"Perit. Dial. Int."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nrneph.2013.99","article-title":"Peritoneal changes in patients on long-term peritoneal dialysis","volume":"9","author":"Krediet","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/bcpt.13038","article-title":"Peritoneal and systemic responses of obese type II diabetic rats to chronic exposure to a hyperbranched polyglycerol-based dialysis solution","volume":"123","author":"La Han","year":"2018","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1681\/asn.2013030314","article-title":"Independent effects of systemic and peritoneal inflammation on peritoneal dialysis survival","volume":"24","author":"Lambie","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/ndt\/gfv440","article-title":"Peritoneal inflammation precedes encapsulating peritoneal sclerosis: results from the GLOBAL Fluid Study","volume":"31","author":"Lambie","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"7692","DOI":"10.3748\/wjg.v22.i34.7692","article-title":"Pathophysiology of colorectal peritoneal carcinomatosis: role of the peritoneum","volume":"22","author":"Lemoine","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref76","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1681\/asn.2012100987","article-title":"Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients","volume":"24","author":"Li","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref77","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.ajpath.2017.03.007","article-title":"miR-21 promotes fibrogenesis in peritoneal dialysis","volume":"187","author":"Lopez-Anton","year":"2017","journal-title":"Am. J. Pathol."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1681\/ASN.2010111197","article-title":"Blocking TGF-\u03b21 protects the peritoneal membrane from dialysate-induced damage","volume":"22","author":"Loureiro","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1093\/ndt\/gfp618","article-title":"BMP-7 blocks mesenchymal conversion of mesothelial cells and prevents peritoneal damage induced by dialysis fluid exposure","volume":"25","author":"Loureiro","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref80","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1046\/j.1524-475X.1999.00477.x","article-title":"Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in mesothelial cells and their regulation by transforming growth factor-beta1","volume":"7","author":"Ma","year":"1999","journal-title":"Wound Repair Regen."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1016\/j.febslet.2007.04.030","article-title":"Chaperonopathies and chaperonotherapy","volume":"581","author":"Macario","year":"2007","journal-title":"FEBS Lett."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1681\/ASN.2004060436","article-title":"Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum","volume":"16","author":"Margetts","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref83","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1681\/ASN.V12102029","article-title":"Gene transfer of transforming growth factor-beta1 to the rat peritoneum: effects on membrane function","volume":"12","author":"Margetts","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1172\/jci116390","article-title":"Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells. Cellular differentiation influences expression","volume":"91","author":"Marshall","year":"1993","journal-title":"J. Clin. Invest."},{"key":"ref85","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/089686080502500509","article-title":"Glucose-free dialysis solutions: inductors of inflammation or preservers of peritoneal membrane?","volume":"25","author":"Martikainen","year":"2005","journal-title":"Perit. Dial. Int."},{"key":"ref86","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1681\/asn.2007111188","article-title":"Relationship between dialysis modality and mortality","volume":"20","author":"McDonald","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref87","doi-asserted-by":"publisher","first-page":"3238","DOI":"10.1681\/asn.2016010112","article-title":"The current state\u00a0of peritoneal dialysis","volume":"27","author":"Mehrotra","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref88","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3747\/pdi.2012.00148","article-title":"Hyperbranched polyglycerol is an efficacious and biocompatible novel osmotic agent in a rodent model of peritoneal dialysis","volume":"33","author":"Mendelson","year":"2013","journal-title":"Perit. Dial. Int."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1681\/asn.2017080828","article-title":"Mechanisms of crystalloid versus colloid osmosis across the peritoneal membrane","volume":"29","author":"Morelle","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref90","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1177\/089686080802803s19","article-title":"Icodextrin and intraperitoneal inflammation","volume":"28","author":"Moriishi","year":"2008","journal-title":"Perit. Dial. Int."},{"key":"ref91","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1097\/01.asn.0000060681.91079.30","article-title":"Effects of conventional and new peritoneal dialysis fluids on leukocyte recruitment in the rat peritoneal membrane","volume":"14","author":"Mortier","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref92","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1111\/j.1523-1755.2005.00237.x","article-title":"Benefits of switching from a conventional to a low-GDP bicarbonate\/lactate-buffered dialysis solution in a rat model","volume":"67","author":"Mortier","year":"2005","journal-title":"Kidney Int."},{"key":"ref93","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1111\/j.1523-1755.2004.00879.x","article-title":"Long-term exposure to new peritoneal dialysis solutions: effects on the peritoneal membrane","volume":"66","author":"Mortier","year":"2004","journal-title":"Kidney Int."},{"key":"ref94","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/nep.12911","article-title":"Risk factors for encapsulating peritoneal sclerosis: analysis of a 36-year experience in a University Hospital","volume":"22","author":"Na kao","year":"2017","journal-title":"Nephrology (Carlton)"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3747\/pdi.2017.00223","article-title":"Associations between peritoneal glucose exposure, glucose degradation product exposure, and peritoneal membrane transport characteristics in peritoneal dialysis patients: secondary analysis of the balANZ trial","volume":"38","author":"Nataatmadja","year":"2018","journal-title":"Perit. Dial. Int."},{"key":"ref96","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1038\/sj.ki.5000285","article-title":"Aquaporin-1 plays an essential role in water permeability and ultrafiltration during peritoneal dialysis","volume":"69","author":"Ni","year":"2006","journal-title":"Kidney Int."},{"key":"ref97","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/089686080902900216","article-title":"Evaluation of taurine as an osmotic agent for peritoneal dialysis solution","volume":"29","author":"Nishimura","year":"2009","journal-title":"Perit. Dial. Int."},{"key":"ref98","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jash.2011.02.004","article-title":"Hypertension in peritoneal dialysis patients: epidemiology, pathogenesis, and treatment","volume":"5","author":"Ortega","year":"2011","journal-title":"J. Am. Soc. Hypertens."},{"key":"ref99","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1172\/jci119868","article-title":"Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells","volume":"100","author":"Papapetropoulos","year":"1997","journal-title":"J. Clin. Invest."},{"key":"ref100","first-page":"186","article-title":"Peritoneal effluent markers of inflammation in patients treated with icodextrin-based and glucose-based dialysis solutions","volume":"19","author":"Parikova","year":"2003","journal-title":"Adv. Perit. Dial."},{"key":"ref101","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1093\/ndt\/17.8.1480","article-title":"Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate","volume":"17","author":"Pecoits-Filho","year":"2002","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref102","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3109\/0886022x.2013.808565","article-title":"Inhibition of Rho-kinase alleviates peritoneal fibrosis and angiogenesis in a rat model of peritoneal dialysis","volume":"35","author":"Peng","year":"2013","journal-title":"Ren. Fail."},{"key":"ref103","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/089686080402400414","article-title":"Amino acid-based peritoneal dialysis solution stimulates mesothelial nitric oxide production","volume":"24","author":"Reimann","year":"2004","journal-title":"Perit. Dial. Int."},{"key":"ref104","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1177\/089686089301302S09","article-title":"A three-pore model of peritoneal transport","volume":"13","author":"Rippe","year":"1993","journal-title":"Perit. Dial. Int."},{"key":"ref105","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000223781","article-title":"Peritoneal angiogenesis in response to dialysis fluid","volume":"163","author":"Rippe","year":"2009","journal-title":"Contrib. Nephrol."},{"key":"ref106","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1161\/01.cir.0000095031.51492.c5","article-title":"Prognostic significance of small-artery structure in hypertension","volume":"108","author":"Rizzoni","year":"2003","journal-title":"Circulation"},{"key":"ref107","first-page":"332","article-title":"V. Observations upon the absorption of fluids by the peritoneum","volume":"25","author":"Robinson","year":"1897","journal-title":"Ann. Surg."},{"key":"ref108","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1053\/j.ajkd.2015.07.031","article-title":"Low-sodium versus standard-sodium peritoneal dialysis solution in hypertensive patients: a randomized controlled trial","volume":"67","author":"Rutkowski","year":"2016","journal-title":"Am. J. Kidney Dis."},{"key":"ref109","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/j.ajpath.2012.08.018","article-title":"Aquaporin 3 expression is up-regulated by TGF-beta1\u00a0in rat peritoneal mesothelial cells and plays a role in wound healing","volume":"181","author":"Ryu","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref110","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.kint.2018.02.022","article-title":"Neutral pH and low-glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal dialysis","volume":"94","author":"Schaefer","year":"2018","journal-title":"Kidney Int."},{"key":"ref111","doi-asserted-by":"publisher","first-page":"21344","DOI":"10.1038\/srep21344","article-title":"Quantitative histomorphometry of the healthy peritoneum","volume":"6","author":"Schaefer","year":"","journal-title":"Sci. Rep."},{"key":"ref112","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s00467-016-3466-6","article-title":"The PD membrane microvasculature in uremia and PD\u2014recent findings from the International Pediatric PD Biobank. Abstracts for the 17th IPNA Congress, Iguacu, Brazil, September 2016: oral presentations","volume":"31","author":"Schaefer","year":"","journal-title":"Pediatr. Nephrol."},{"key":"ref113","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1007\/s00467-016-3461-y","article-title":"Is there such a thing as biocompatible peritoneal dialysis fluid?","volume":"32","author":"Schmitt","year":"2016","journal-title":"Pediatr. Nephrol."},{"key":"ref114","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00467-011-1863-4","article-title":"Solutions for peritoneal dialysis in children: recommendations by the European Pediatric Dialysis Working Group","volume":"26","author":"Schmitt","year":"2011","journal-title":"Pediatr. Nephrol."},{"key":"ref115","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1046\/j.1523-1755.2002.00255.x","article-title":"Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children","volume":"61","author":"Schmitt","year":"2002","journal-title":"Kidney Int."},{"key":"ref116","doi-asserted-by":"publisher","first-page":"108","DOI":"10.2215\/CJN.00690112","article-title":"Effect of the dialysis fluid buffer on peritoneal membrane function in children","volume":"8","author":"Schmitt","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref117","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1093\/ndt\/gfm148","article-title":"Reduced systemic advanced glycation end products in children receiving peritoneal dialysis with low glucose degradation product content","volume":"22","author":"Schmitt","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref118","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3747\/pdi.2014.00049","article-title":"Genetic polymorphisms and peritoneal membrane function","volume":"35","author":"Siddique","year":"2015","journal-title":"Perit. Dial. Int."},{"key":"ref119","doi-asserted-by":"publisher","first-page":"F1331","DOI":"10.1152\/ajprenal.00301.2011","article-title":"Computer simulations of osmotic ultrafiltration and small-solute transport in peritoneal dialysis: a spatially distributed approach","volume":"302","author":"Stachowska-Pietka","year":"2012","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref120","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1681\/asn.2014101047","article-title":"Uremic toxicity of advanced glycation end products in CKD","volume":"27","author":"Stinghen","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref121","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/01.asn.0000053420.37216.9e","article-title":"Corticosteroids induce expression of aquaporin-1 and increase transcellular water transport in rat peritoneum","volume":"14","author":"Stoenoiu","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref122","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000186553","article-title":"Functional characteristics of the peritoneal membrane in long-term continuous ambulatory peritoneal dialysis","volume":"59","author":"Struijk","year":"1991","journal-title":"Nephron"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3132\/dvdr.2006.001","article-title":"Adipose tissue metabolism, diabetes and vascular disease\u2014lessons from in\u00a0vivo studies","volume":"3","author":"Summers","year":"2006","journal-title":"Diab. Vasc. Dis. Res."},{"key":"ref124","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1126\/science.282.5388.468","article-title":"Increased vascularization in mice overexpressing angiopoietin-1","volume":"282","author":"Suri","year":"1998","journal-title":"Science"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1093\/ndt\/gfl559","article-title":"Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation products\u2014a 1-year randomized control trial","volume":"22","author":"Szeto","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref126","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/sj.ki.5002040","article-title":"Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model","volume":"71","author":"Tanabe","year":"2007","journal-title":"Kidney Int."},{"key":"ref127","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1365-2249.2004.02407.x","article-title":"Regulation of complement C3 and C4 synthesis in human peritoneal mesothelial cells by peritoneal dialysis fluid","volume":"136","author":"Tang","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"ref128","doi-asserted-by":"publisher","first-page":"74","DOI":"10.2215\/cjn.01370406","article-title":"Peritoneal dialysis with solutions containing amino acids plus glucose promotes protein synthesis during oral feeding","volume":"2","author":"Tjiong","year":"2007","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref129","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1681\/asn.2004050402","article-title":"Dialysate as food: combined amino acid and glucose dialysate improves protein anabolism in renal failure patients on automated peritoneal dialysis","volume":"16","author":"Tjiong","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref130","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/ki.1988.195","article-title":"The effect of dialysate on peritoneal phagocyte oxidative metabolism","volume":"34","author":"Topley","year":"1988","journal-title":"Kidney Int."},{"key":"ref131","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/ki.1993.36","article-title":"Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1 beta and TNF alpha","volume":"43","author":"Topley","year":"1993","journal-title":"Kidney Int."},{"key":"ref132","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1681\/ASN.V72218","article-title":"In vitro effects of bicarbonate and bicarbonate-lactate buffered peritoneal dialysis solutions on mesothelial and neutrophil function","volume":"7","author":"Topley","year":"1996","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref133","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.tice.2016.11.004","article-title":"The histophysiology and pathophysiology of the peritoneum","volume":"49","author":"van Baal","year":"2017","journal-title":"Tissue Cell"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/ndt\/gfv295","article-title":"Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period","volume":"31","author":"van de Luijtgaarden","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref135","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.cca.2013.12.003","article-title":"Peritoneal dialysis and inflammation","volume":"430","author":"Velloso","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.kint.2018.08.031","article-title":"A randomized controlled trial of alanyl-glutamine in peritoneal dialysis fluids to assess impact on biomarkers of peritoneal health and systemic inflammation","volume":"94","author":"Vychytil","year":"2018","journal-title":"Kidney Int."},{"key":"ref137","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12882-015-0175-5","article-title":"Impact of initial dialysis modality on mortality: a propensity-matched study","volume":"16","author":"Waldum-Grevbo","year":"2015","journal-title":"BMC Nephrol."},{"key":"ref138","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1681\/ASN.V132470","article-title":"Morphologic changes in the peritoneal membrane of patients with renal disease","volume":"13","author":"Williams","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref139","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/j.1523-1755.2004.00747.x","article-title":"The Euro-balance trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane","volume":"66","author":"Williams","year":"2004","journal-title":"Kidney Int."},{"key":"ref140","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3892\/mmr.2013.1478","article-title":"Soluble Tie2 fusion protein decreases peritoneal angiogenesis in uremic rats","volume":"8","author":"Xiao","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"ref141","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa020809","article-title":"Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells","volume":"348","author":"Yanez-Mo","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref142","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.2215\/CJN.05410514","article-title":"Effect of neutral-pH, low-glucose degradation product peritoneal dialysis solutions on residual renal function, urine volume, and ultrafiltration: a systematic review and meta-analysis","volume":"10","author":"Yohanna","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref143","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1681\/asn.2012080869","article-title":"AqF026 is a pharmacologic agonist of the water channel aquaporin-1","volume":"24","author":"Yool","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref144","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1111\/j.1523-1755.2004.00935.x","article-title":"TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model","volume":"66","author":"Yoshio","year":"2004","journal-title":"Kidney Int."},{"key":"ref145","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1046\/j.1523-1755.2003.00705.x","article-title":"Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation?","volume":"63","author":"Zeier","year":"2003","journal-title":"Kidney Int."},{"key":"ref146","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.imbio.2016.06.107","article-title":"Complement biomarkers in the management of peritoneal dialysis","volume":"221","author":"Zelek","year":"2016","journal-title":"Immunobiology"},{"key":"ref147","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.atherosclerosis.2016.08.029","article-title":"Genetics links between transforming growth factor beta pathway and coronary disease","volume":"253","author":"Zeng","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s00467-012-2120-1","article-title":"Buffer-dependent regulation of aquaporin-1 expression and function in human peritoneal mesothelial cells","volume":"27","author":"Zhai","year":"2012","journal-title":"Pediatr. Nephrol."},{"key":"ref149","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.kint.2016.03.040","article-title":"Preventing peritoneal membrane fibrosis in peritoneal dialysis patients","volume":"90","author":"Zhou","year":"2016","journal-title":"Kidney Int."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphys.2018.01853\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T20:40:06Z","timestamp":1662756006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphys.2018.01853\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,7]]},"references-count":149,"alternative-id":["10.3389\/fphys.2018.01853"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2018.01853","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,7]]},"article-number":"1853"}}